Juda Scott has filed 24 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 150000 shares of Inmune Bio, Inc. ($INMB) on December 01, 2025.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 1, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | A | Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 26,585,258 | 9999.99% | 0.56% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | A | Stock Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 26,585,258 | 9999.99% | 0.05% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | D | Stock Option (right to buy) | 108000 | $0.00 | 0.0000 | 26,585,258 | 100.00% | 0.41% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | A | Stock Option (right to buy) | 108000 | $0.00 | 108,000.0000 | 26,585,258 | 9999.99% | 0.41% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | D | Stock Option (right to buy) | 108000 | $0.00 | 0.0000 | 26,585,258 | 100.00% | 0.41% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | A | Stock Option (right to buy) | 108000 | $0.00 | 108,000.0000 | 26,585,258 | 9999.99% | 0.41% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | D | Stock Option (right to buy) | 15975 | $0.00 | 0.0000 | 26,585,258 | 100.00% | 0.06% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | A | Stock Option (right to buy) | 15975 | $0.00 | 15,975.0000 | 26,585,258 | 9999.99% | 0.06% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | D | Stock Option (right to buy) | 19025 | $0.00 | 0.0000 | 26,585,258 | 100.00% | 0.07% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | A | Stock Option (right to buy) | 19025 | $0.00 | 19,025.0000 | 26,585,258 | 9999.99% | 0.07% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | D | Stock Option (right to buy) | 35000 | $0.00 | 0.0000 | 26,585,258 | 100.00% | 0.13% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 26,585,258 | 9999.99% | 0.13% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | D | Stock Option (right to buy) | 35000 | $0.00 | 0.0000 | 26,585,258 | 100.00% | 0.13% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 26,585,258 | 9999.99% | 0.13% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | D | Stock Option (right to buy) | 32500 | $0.00 | 0.0000 | 26,585,258 | 100.00% | 0.12% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | D | Stock Option (right to buy) | 12500 | $0.00 | 0.0000 | 26,585,258 | 100.00% | 0.05% |
| Nov. 18, 2025 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | A | Stock Option (right to buy) | 32500 | $0.00 | 32,500.0000 | 26,585,258 | 9999.99% | 0.12% |
| Dec. 5, 2024 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | A | Option (right to buy) | 32500 | $0.00 | 32,500.0000 | 20,185,676 | 9999.99% | 0.16% |
| June 25, 2024 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | P | Common Stock | 5000 | $7.27 | 71,603.0000 | 18,026,473 | 7.51% | 0.03% |
| May 14, 2024 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | A | Option (right to buy) | 12500 | $0.00 | 12,500.0000 | 18,026,473 | 9999.99% | 0.07% |
| April 19, 2024 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | P | Common Stock | 29603 | $8.32 | 66,603.0000 | 18,026,473 | 80.01% | 0.16% |
| April 19, 2024 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | P | Common Stock Warrants (right to buy) | 29603 | $0.13 | 29,603.0000 | 18,026,473 | 9999.99% | 0.16% |
| April 19, 2024 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | A | Common Stock | 29603 | $8.32 | 66,603.0000 | 18,026,473 | 80.01% | 0.16% |
| April 19, 2024 | Inmune Bio, Inc. | $INMB | Juda Scott | Director | A | Common Stock Warrants (right to buy) | 29603 | $0.13 | 29,603.0000 | 18,026,473 | 9999.99% | 0.16% |